Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2019-11-11 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Roxadustat pooled analyses: no increased CV risk
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content is a press release detailing positive efficacy and cardiovascular safety data from Phase III clinical trials for the drug Roxadustat, presented at a medical conference (ASN Kidney Week 2019). This type of announcement, which releases material, non-financial news to the market via an official channel, fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG, DIRS). Although it contains scientific data, its primary function here is a broad market disclosure via RNS.
2019-11-11 English
ROXADUSTAT SIGNIFICANTLY INCREASED HAEMOGLOBIN LEVELS FOR CHRONIC KIDNEY DISEASE
Regulatory Filings
2019-11-08 English
FORM F-3ASR
Regulatory Filings
2019-11-08 English
Roxadustat significantly increased haemoglobin
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content is a press release detailing positive Phase III clinical trial results (OLYMPUS and ROCKIES) for a drug (Roxadustat) and mentions that the data will form part of a future regulatory submission. Since this is a general announcement of clinical trial results and corporate news distributed through the RNS system, and it does not fit the specific definitions for Earnings Release (ER), Interim Report (IR), or Audit Report (AR), the most appropriate classification is the general regulatory announcement category, RNS.
2019-11-08 English
CALQUENCE DATA TO SHOW IMPROVED PROGRESSION-FREE SURVIVAL IN PHASE III FRONT-LIN
Regulatory Filings
2019-11-06 English
Calquence data to show improved progression-free
Earnings Release Classification · 99% confidence The document is a press release dated November 6, 2019, identified by the RNS Number '5205S' and the standard format of a corporate announcement. It details upcoming data presentations (Phase III ELEVATE-TN trial results for Calquence) at the American Society of Hematology (ASH) Annual Meeting. This is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal proxy/remuneration document. It is an announcement about scientific/clinical data and upcoming presentations, which falls under general regulatory announcements or investor relations material. Since it is explicitly marked with an RNS Number and serves as a broad regulatory update regarding clinical trial progress, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that doesn't fit the more specific categories like ER, MDA, or IP, although it contains elements of scientific disclosure. FY 2019
2019-11-06 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.